Choline Dose Ranging in Postmenopausal Women

Completed · Not applicable · Has a placebo group

Conditions studied: Menopause

In brief

This study will use a randomized placebo-controlled trial to examine smaller doses of choline and whether a signal in the brain is detectable using fMRI. This study will examine if an even smaller doses of choline can show these similar brain activation and connectivity patterns to the 1650 mg dose. This will be a dose ranging study of 550 mg and 1100 mg oral choline compared to placebo.

Key facts

Study ID
NCT06924541
Run by
Julie Dumas
People needed
20
Starts
2024-09-01
Expected to finish
2026-03-01
Last updated by the study team
2026-05-04

Who can join

Age: 50 and older, up to 65. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.